PAD Special Edition: Intro to Paxlovid™ (nirmatrelvir/ritonavir)

Personalized education in 30-60 minutes via in-person visit or web conferencing (e.g., Zoom or WebEx) at a time that is convenient for you.

Note: This topic has not been accredited for Mainpro+ credits due to a need to develop the educational session urgently.

Learning objectives

During each academic detailing session, participants will have the opportunity to:

  • Discuss an overview of nirmatrelvir/ritonavir including:
    • EPIC-HR trial
    • eligibility criteria
  • Review clinical considerations which support treatment decisions including:
    • contraindications
    • drug-drug interactions
    • dosing (usual and renal)


When: Until June 2022
Where: Virtual academic detailing session
How: Email to schedule a time for your group


For more information about the PAD service, visit PAD Frequently Asked Questions.